Rhumbline Advisers lifted its holdings in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) by 10.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 183,279 shares of the business services provider’s stock after buying an additional 17,280 shares during the quarter. Rhumbline Advisers owned approximately 0.36% of Exponent worth $18,271,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. Venturi Wealth Management LLC acquired a new position in shares of Exponent during the 1st quarter worth approximately $25,000. Benjamin Edwards Inc. raised its stake in shares of Exponent by 92.1% during the 1st quarter. Benjamin Edwards Inc. now owns 465 shares of the business services provider’s stock worth $46,000 after buying an additional 223 shares during the period. CI Investments Inc. raised its stake in shares of Exponent by 24.6% during the 4th quarter. CI Investments Inc. now owns 521 shares of the business services provider’s stock worth $52,000 after buying an additional 103 shares during the period. Belpointe Asset Management LLC acquired a new position in shares of Exponent during the 4th quarter worth approximately $56,000. Finally, Point72 Hong Kong Ltd acquired a new position in shares of Exponent during the 1st quarter worth approximately $74,000. 89.31% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on EXPO shares. TheStreet downgraded Exponent from a “b” rating to a “c+” rating in a research note on Wednesday, May 17th. UBS Group initiated coverage on Exponent in a research note on Wednesday, May 31st. They issued a “neutral” rating and a $99.00 price objective for the company. StockNews.com initiated coverage on Exponent in a research note on Thursday, August 17th. They issued a “hold” rating for the company. Finally, Truist Financial reduced their price objective on Exponent from $120.00 to $110.00 and set a “buy” rating for the company in a research note on Monday, July 31st. Three equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $104.50.
Exponent Stock Down 0.1 %
Shares of EXPO opened at $91.16 on Thursday. Exponent, Inc. has a 52-week low of $85.27 and a 52-week high of $112.75. The company has a market capitalization of $4.64 billion, a PE ratio of 46.27 and a beta of 0.62. The stock has a fifty day simple moving average of $91.70 and a two-hundred day simple moving average of $95.15.
Exponent (NASDAQ:EXPO – Get Free Report) last issued its earnings results on Thursday, July 27th. The business services provider reported $0.50 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.51 by ($0.01). Exponent had a return on equity of 30.41% and a net margin of 19.03%. The company had revenue of $129.65 million during the quarter, compared to analyst estimates of $130.40 million. During the same period last year, the business earned $0.49 earnings per share. The firm’s revenue was up 9.7% compared to the same quarter last year. As a group, equities analysts anticipate that Exponent, Inc. will post 2.05 earnings per share for the current fiscal year.
Exponent Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, September 22nd. Shareholders of record on Friday, September 8th will be paid a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a dividend yield of 1.14%. The ex-dividend date of this dividend is Thursday, September 7th. Exponent’s dividend payout ratio (DPR) is presently 52.79%.
Insiders Place Their Bets
In other Exponent news, VP Steven J. Murray sold 1,000 shares of the firm’s stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $86.77, for a total value of $86,770.00. Following the completion of the sale, the vice president now directly owns 28,412 shares of the company’s stock, valued at approximately $2,465,309.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 2.20% of the company’s stock.
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
- Five stocks we like better than Exponent
- How Investors Can Find the Best Cheap Dividend Stocks
- Why Ambarella’s 20% Decline is a Strong Signal for New Investment
- How to Invest in the Best Canadian Stocks
- Why Analysts Love These 2 Car Sales Platforms, And Avoid Dealers
- What Does a Stock Split Mean?
- A Significant Reversal is in Sight for These 5 Med Tech Companies
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.